Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GenOdyssee S.A.
DescriptionAntiviral interferon (IFN) alpha 17 variant
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis
Indication DetailsTreat hepatitis C infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today